Catalyst Wire Dossier Catalyst Wire Dossier

Paclitaxel cationic liposome (hepatic arterial infusion)

paclitaxel in cationic liposome formulation for hepatic arterial infusion · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Paclitaxel cationic liposome (hepatic arterial infusion), covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases [Phase 1]

See pricing